Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung
Recruiting
Observational Study
Healthy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 40 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- Hvidovre University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall aim is to to provide a normal material for the composition and spatial heterogeneity of the following in the healthy lung: i) immune cell populations and their activation patterns, ii) the surrounding cytokine-chemokine milieu, including trans-compartmental fluxes of these mediators between the lung and bloodstream, and iii) the lung microbiome.
Main hypotheses:
* Absolute and relati…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men and women
* Age 40 to 75
Exclusion Criteria:
* Immune deficiency
* Lung disease
* Active cancer or infection
* Absolute contraindications for bronchoscopy
* Untreated malignant arrhythmia
* Documented or suspected intracranial hypertension (intracranial pressure ≥ \…
Contacts